EWP
GSK icon

Elevation Wealth Partners’s GSK GSK Stock Holding History

Elevation Wealth Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.6K Buy
+164
New +$8.67K ﹤0.01% 855

Other funds holding GSK

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
SIS
Sound Income Strategies Ft Lauderdale, Florida $2.23B AUM 11.22% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return

Elevation Wealth Partners's GSK Position: Q2 2026 in Review

Elevation Wealth Partners opened a new position in GSK (GSK) in Q2 2026: 164 shares worth $8.6K. The stake represents ﹤0.01% of the portfolio and ranks #855 among its holdings.

399 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Elevation Wealth Partners held 164 shares of GSK worth $8.6K as of Q2 2026.
  • GSK was a new Elevation Wealth Partners position in Q2 2026.
  • GSK made up ﹤0.01% of Elevation Wealth Partners's portfolio in Q2 2026, its #855 holding.
  • 399 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.